Rapid test for pathogens developed by K-State researchers

Aug 22, 2008

Dangerous disease often spreads faster than it takes to diagnose it in the lab. To remedy that, researchers at Kansas State University have developed a test to bring that time from days down to hours.

Sanjeev Narayanan, assistant professor, and Greg Peterson, research microbiologist, both in the department of diagnostic medicine and pathobiology, use a device called a DNA spotted microarray to seek out the specific genetic markers that set one pathogen apart from another and determine antibiotic resistance.

Traditionally, it takes days and multiple lab workers to screen a sample of soil, water or feces for just one pathogen. Additional time is then needed to look for resistance to antibiotics. The new test developed at K-State simultaneously looks for multiple diseases and antibiotic resistance, reducing the time it takes from sampling to diagnosis to about 24 hours.

"We needed a mass, high through-put system," Narayanan said. "The longer a serious disease goes undiagnosed, the harder it is to treat and the further it can spread."

Narayanan and Peterson have analyzed DNA of hundreds of pathogens and synthesized DNA probes for the specific genetic sequences that set each pathogen apart. So far they can detect as many as 557 genes, making it possible for them to screen for 40 different species of bacteria, 1,200 serotypes of Salmonella, five common serotypes of E. coli, and resistance to the 45 most common antibiotics used to treat human and animal illnesses caused by these pathogens.

When a sample is submitted, technicians extract and fluorescently label total DNA, and run a microarray to check whether a particular gene is present. Narayanan said the next step will be to develop a test that indicates how much of a pathogen is present, or rather how bad an infection is.

Narayanan said that he and Peterson developed the test because most human and animal infections are caused by a mixture of pathogens.

Under the current practice, it literally takes days to isolate and identify each individual pathogen and generate their antimicrobial resistance profiles. This means physicians and veterinarians often start antibiotic treatment before knowing exactly what they're up against.

"This new test will eliminate a lot of the guesswork," Narayanan said. It will tell the doctor how many different kinds of pathogens are in a sample and which antibiotics won't work, all in a shorter time frame. The test's efficiencies also translate into lower cost, he said.

Should the U.S. ever be attacked with biological weapons, Narayanan said the new test also will help in quickly identifying all of the bacterial pathogens used.

"Being able to get such quick results for so many pathogens at once will become critical in case of bioterrorism," he said. "Under that scenario, every minute counts in providing treatment or preventing disease spread."

Also, such pathogens would likely be engineered for resistance to common drug treatment and the new test would determine such resistance rapidly, Narayanan said.

The test is currently being used in research labs at K-State's College of Veterinary Medicine to detect animal and zoonotic pathogens; zoonotic pathogens can be transmitted between humans and animals. The test also is being used to monitor the flow of genetic elements in food production systems, such as feedlots. However, Narayanan hopes the test one day will be used to enhance the clinical diagnosis of animal and human infections.

Source: Kansas State University

Explore further: Bird flu confirmed at Iowa farm with 5.3 million chickens

Related Stories

European physicist discusses Higgs boson at Brown University

3 hours ago

The head of the European Organization for Nuclear Research says the historic 2012 discovery of the Higgs boson particle and the particle accelerator that detected it are getting scientists closer to understanding the creation ...

IBM earnings dip as sales fall again

3 hours ago

Technology heavyweight IBM reported Monday lower profits in the first quarter following another drop in revenues, this time partly due to the strong dollar.

Recommended for you

Cancer drug shows promise as cure for hepatitis B

6 hours ago

Australian scientists have found a potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models.

One test for all infections

8 hours ago

If you're returning from abroad with a fever, your doctor will likely test you for malaria. You'll give multiple blood samples at the lab, and if the results are inconclusive, you'll face yet another round of tests.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.